Calpain‐4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Experimental Alcohol‐Related Liver Disease
Alcohol, Clinical and Experimental Research · 2026-06 · 50 (6)
DOI: 10.1111/acer.70356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 17.06.2026. Verfasst von Noriko Kitano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Calpain, Liver X Receptors, Cholesterol, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Ethanol affects lipid metabolism through multiple pathways, leading to fatty liver development in most alcohol‐related liver disease (ALD) patients. Recent studies have highlighted the role of calpain, a calcium‐dependent protease, in liver inflammation and fibrosis. Calpain activity is regulated by its essential subunit, Capns1 (calpain‐4), which stabilizes and modulates the activity of its catalytic isoforms, calpain‐1 and calpain‐2. This study investigated calpain's impact on lipid metabolism in ALD.
Methods
Six‐week‐old C57Bl6/J mice were injected with rAAV8 vectors encoding Capns1 shRNA or control vectors. After 4 weeks, mice underwent a 10‐day period of ad libitum ethanol consumption, followed by a single gavaged ethanol administration on day 11.
Results
Capns1 knockdown attenuated ethanol‐induced microvesicular steatosis. Hepatic triglyceride and free fatty acid levels were not significantly altered, whereas cholesterol levels were significantly reduced in the ethanol group with Capns1 knockdown. Cpt1a expression increased significantly in the ethanol group with Capns1 knockdown. Western blot analysis revealed increased Cleaved‐3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A reductase (HMGCR) to Pro‐HMGCR ratio in Capns1‐knockdown mice, suggesting reduced HMGCR activity and suppressed cholesterol biosynthesis. LXRα expression was mainly increased in the cytoplasm in the ethanol group, and following Capns1 knockdown, it was relocalized to the nucleus via its activation. In addition, RNA sequencing analysis indicated that Capns1 knockdown contributes to the reprogramming of ethanol‐induced disruptions in metabolic pathways, primarily those involving cholesterol metabolism.
Conclusion
Further investigation into the relationship between Capns1 and cholesterol biosynthesis proteins may provide insights into using calpain inhibitors as a therapeutic approach for alcohol‐related liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Organ Pathobiology and Therapeutics Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Liver Unit, Department of Internal Medicine, Clinical University of Navarra, Pamplona, Navarra, Spain.
ORCID-Profile: Jiang Li
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kitano, N., Li, J., Taborski, S., Vanderpuye, C. M., Muddasani, P., Chaudhary, S., Liu, J. J., Liu, S., Beier, J. I., Argemi, J., Bataller, R., & Arteel, G. E. (2026). Calpain‐4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Experimental Alcohol‐Related Liver Disease. Alcohol, Clinical and Experimental Research, 50(6). https://doi.org/10.1111/acer.70356
Vancouver
Kitano N, Li J, Taborski S, Vanderpuye CM, Muddasani P, Chaudhary S, et al. Calpain‐4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Experimental Alcohol‐Related Liver Disease. Alcohol, Clinical and Experimental Research. 2026;50(6). doi:10.1111/acer.70356
BibTeX
@article{Kitano2026,
author = {Kitano, Noriko and Li, Jiang and Taborski, Sam and Vanderpuye, Charis-Marie and Muddasani, Pooja and Chaudhary, Sudrishti and Liu, Jia-Jun and Liu, Silvia and Beier, Juliane I and Argemi, Josepmaria and Bataller, Ramon and Arteel, Gavin E},
title = {Calpain‐4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Experimental Alcohol‐Related Liver Disease},
journal = {Alcohol, Clinical and Experimental Research},
year = {2026},
volume = {50},
number = {6},
doi = {10.1111/acer.70356}
}
EUVIMED